IDN-6556

· Conatus Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for IDN-6556, covering 2016-01-28 to 2019-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV [Phase 2]